|
1
|
Reiss J, Iglseder B, Alzner R, Mayr-Pirker
B, Pirich C, Kässmann H, Kreutzer M, Dovjak P and Reiter R:
Consequences of applying the new EWGSOP2 guideline instead of the
former EWGSOP guideline for sarcopenia case finding in older
patients. Age Ageing. 48:719–724. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Chen LK, Liu LK, Woo J, Assantachai P,
Auyeung TW, Bahyah KS, Chou MY, Chen LY, Hsu PS, Krairit O, et al:
Sarcopenia in Asia: Consensus report of the asian working group for
sarcopenia. J Am Med Dir Assoc. 15:95–101. 2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Nishikawa H, Shiraki M, Hiramatsu A,
Moriya K, Hino K and Nishiguchi S: Japan Society of Hepatology
guidelines for sarcopenia in liver disease (1st edition):
Recommendation from the working group for creation of sarcopenia
assessment criteria. Hepatol Res. 46:951–963. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Schneider DA and Trence DL: Possible role
of nutrition in prevention of sarcopenia and falls. Endocr Pract.
25:1184–1190. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Sawada Y, Kawaratani H, Kubo T, Fujinaga
Y, Furukawa M, Saikawa S, Sato S, Takaya H, Kaji k, Shimozato N, et
al: Effect of furosemide on muscle cramps in patients with liver
cirrhosis. J Gastroenterol Hepatol. 35:76–81. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Chang KV, Chen JD, Wu WT, Huang KC, Lin HY
and Han DS: Is sarcopenia associated with hepatic encephalopathy in
liver cirrhosis? A systematic review and meta-analysis. J Formos
Med Assoc. 118:833–842. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Praktiknjo M, Clees C, Pigliacelli A,
Fischer S, Jansen C, Lehmann J, Pohlmann A, Lattanzi B, Krabbe VK,
Strassburg CP, et al: Sarcopenia is associated with development of
acute-on-chronic liver failure in decompensated liver cirrhosis
receiving transjugular intrahepatic portosystemic shunt. Clin
Transl Gastroenterol. 10(e00025)2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kamachi S, Mizuta T, Otsuka T, Nakashita
S, Ide Y, Miyoshi A, Kitahara K, Eguchi Y, Ozaki I and Anzai K:
Sarcopenia is a risk factor for the recurrence of hepatocellular
carcinoma after curative treatment. Hepatol Res. 46:201–208.
2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Hanai T, Shiraki M, Nishimura K, Ohnishi
S, Imai K, Suetsugu A, Takai K, Shimizu M and Moriwaki H:
Sarcopenia impairs prognosis of patients with liver cirrhosis.
Nutrition. 31:193–199. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ohara M, Ogawa K, Suda G, Kimura M,
Maehara O, Shimazaki T, Suzuki K, Nakamura A, Umemura M, Izumi T,
et al: L-Carnitine suppresses loss of skeletal muscle mass in
patients with liver cirrhosis. Hepatol Commun. 2:906–918.
2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hiramatsu A, Aikata H, Uchikawa S, Ohya K,
Kodama K, Nishida Y, Daijo K, Osawa M, Teraoka Y, Honda F, et al:
Levocarnitine use is associated with improvement in sarcopenia in
patients with liver cirrhosis. Hepatol Commun. 3:348–355.
2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hiraoka A, Kiguchi D, Ninomiya T, Hirooka
M, Abe M, Matsuura B, Hiasa Y and Michitaka K: Can L-carnitine
supplementation and exercise improve muscle complications in
patients with liver cirrhosis who receive branched-chain amino acid
supplementation? Eur J Gastroenterol Hepatol. 31:878–884.
2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Gomarasca M, Banfi G and Lombardi G:
Myokines: The endocrine coupling of skeletal muscle and bone. Adv
Clin Chem. 94:155–218. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Delezie J and Handschin C: Endocrine
crosstalk between skeletal muscle and the brain. Front Neurol.
9(698)2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Colaianni G, Mongelli T, Cuscito C,
Pignataro P, Lippo L, Spiro G, Notarnicola A, Severi I, Passeri G,
Mori G, et al: Irisin prevents and restores bone loss and muscle
atrophy in hind-limb suspended mice. Sci Rep.
7(2811)2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kanzleiter T, Rath M, Görgens SW, Jensen
J, Tangen DS, Kolnes AJ, Kolnes KJ, Lee S, Eckel J, Schürmann A and
Eckardt K: The myokine decorin is regulated by contraction and
involved in muscle hypertrophy. Biochem Biophys Res Commun.
450:1089–1094. 2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Rodriguez J, Vernus B, Chelh I,
Cassar-Malek I, Gabillard JC, Hadj Sassi A, Seiliez I, Picard B and
Bonnieu A: Myostatin and the skeletal muscle atrophy and
hypertrophy signaling pathways. Cell Mol Life Sci. 71:4361–4371.
2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Garcia PS, Cabbabe A, Kambadur R, Nicholas
G and Csete M: Brief-reports: Elevated myostatin levels in patients
with liver disease: A potential contributor to skeletal muscle
wasting. Anesth Analg. 111:707–709. 2010.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Nishikawa H, Enomoto H, Ishii A, Iwata Y,
Miyamoto Y, Ishii N, Yuri Y, Hasegawa K, Nakano C, Nishimura T, et
al: Elevated serum myostatin level is associated with worse
survival in patients with liver cirrhosis. J Cachexia Sarcopenia
Muscle. 8:915–925. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Skladany L, Koller T, Molcan P, Vnencakova
J, Zilincan M, Jancekova D and Kukla M: Prognostic usefulness of
serum myostatin in advanced chronic liver disease: Its relation to
gender and correlation with inflammatory status. J Physiol
Pharmacol. 70:357–368. 2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Sterling RK, Lissen E, Clumeck N, Sola R,
Correa MC, Montaner J, S Sulkowski M, Torriani FJ, Dieterich DT,
Thomas DL, et al: Development of a simple noninvasive index to
predict significant fibrosis in patients with HIV/HCV coinfection.
Hepatology. 43:1317–1325. 2006.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Vallet-Pichard A, Mallet V and Pol S:
FIB-4: A simple, inexpensive and accurate marker of fibrosis in
HCV-infected patients. Hepatology. 44:769–770. 2006.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Matsuo S, Imai E, Horio M, Yasuda Y,
Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A,
Collaborators developing the Japanese equation for estimated GFR
, et al: Revised equations for estimated GFR from serum
creatinine in Japan. Am J Kidney Dis. 53:982–992. 2009.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Shiraki M, Shimizu M, Moriwaki H, Okita K
and Koike K: Carnitine dynamics and their effects on hyperammonemia
in cirrhotic Japanese patients. Hepatol Res. 47:321–327.
2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Abbasnezhad A, Choghakhori R, Kashkooli S,
Alipour M, Asbaghi O and Mohammadi R: Effect of L-carnitine on
liver enzymes and biochemical factors in hepatic encephalopathy: A
systematic review and meta-analysis. J Gastroenterol Hepatol.
34:2062–2070. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Frederick RT: Current concepts in the
pathophysiology and management of hepatic encephalopathy.
Gastroenterol Hepatol (N Y). 7:222–233. 2011.PubMed/NCBI
|
|
27
|
Matsui H, Einama T, Shichi S, Kanazawa R,
Shibuya K, Suzuki T, Matsuzawa F, Hashimoto T, Homma S, Yamamoto J,
et al: L-Carnitine supplementation reduces the general fatigue of
cancer patients during chemotherapy. Mol Clin Oncol. 8:413–416.
2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Nakanishi H, Kurosaki M, Tsuchiya K,
Nakakuki N, Takada H, Matsuda S, Gondo K, Asano Y, Hattori N,
Tamaki N, et al: L-carnitine reduces muscle cramps in patients with
cirrhosis. Clin Gastroenterol Hepatol. 13:1540–1543.
2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Schneider CM, Dennehy CA, Rodearmel SJ and
Hayward JR: Effects of physical activity on creatine phosphokinase
and the isoenzyme creatine kinase-MB. Ann Emerg Med. 25:520–524.
1995.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Baird MF, Graham SM, Baker JS and
Bickerstaff GF: Creatine-kinase- and exercise-related muscle damage
implications for muscle performance and recovery. J Nutr Metab.
2012(960363)2012.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Das AK, Yang QY, Fu X, Liang JF, Duarte
MS, Zhu MJ, Trobridge GD and Du M: AMP-activated protein kinase
stimulates myostatin expression in C2C12 cells. Biochem Biophys Res
Commun. 427:36–40. 2012.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Gnoni A, Longo S, Gnoni GV and Giudetti
AM: Carnitine in human muscle bioenergetics: Can carnitine
supplementation improve physical exercise? Molecules.
25(182)2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Herzig S and Shaw RJ: AMPK: Guardian of
metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol.
19:121–135. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Stella C, Beckwith-Hall B, Cloarec O,
Holmes E, Lindon JC, Powell J, van der Ouderaa F, Bingham S, Cross
AJ and Nicholson JK: Susceptibility of human metabolic phenotypes
to dietary modulation. J Proteome Res. 5:2780–2788. 2006.PubMed/NCBI View Article : Google Scholar
|
